Acute lymphocytic leukaemia recurrent

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 1 Phase I: 1 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

1 trial
  • Nosokomeio Paidon I Agia Sofia Academic
    DDCART‐CD19
    2024-516091-15-00 1 country 2022 n=8
    Recruiting

Phase I

1 trial
  • Institut Paoli Calmettes Academic
    IMP not specified
    2024-518265-10-01 1 country 2020 n=24
    Ended

Phase I (First in Human)

1 trial
  • AstraZeneca AB Commercial
    AZD3632
    2025-521299-76-00 3 countries 2025 n=17
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AstraZeneca AB Commercial 1 Phase I (First in Human) 1
Institut Paoli Calmettes Academic 1 Phase I 0
Nosokomeio Paidon I Agia Sofia Academic 1 Phase II 1
New trials by year
2020
1
2022
1
2025
1
← All indication landscapes